Skip to main content Accessibility help
  • Print publication year: 2010
  • Online publication date: February 2010

Chapter 1 - Maternal adaptations to pregnancy and the role of the placenta

from Section 1 - Nutritional regulation and requirements for pregnancy and fetal growth

Related content

Powered by UNSILO


1. ThompsonJA, HaysPM, SagarKB, and CruikshankDP, Echocardiographic left ventricular mass to differentiate chronic hypertension from preeclampsia during pregnancy. Am J Obstet Gynecol (1986), 155:994–9.
2. SpaandermanME, WillekesC, HoeksAP, EkhartTH, and PeetersLL, The effect of pregnancy on the compliance of large arteries and veins in healthy parous control subjects and women with a history of preeclampsia. Am J Obstet Gynecol (2000), 183:1278–86.
3. PritchardJA, Changes in the blood volume during pregnancy and delivery. Anesthesiology (1965), 26:393–9.
4. KollerO, The clinical significance of hemodilution during pregnancy. Obstet Gynecol Surv (1982), 37:649–52.
5. RobsonSC, HunterS, BoysRJ, and DunlopW, Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol (1989), 256:H1060–5.
6. GreissFC Jr.and Anderson SG, Effect of ovarian hormones on the uterine vascular bed. Am J Obstet Gynecol (1970), 107:829–36.
7. ChristensenT, KlebeJG, BertelsenV, and HansenHE, Changes in renal volume during normal pregnancy. Acta Obstet Gynecol Scand (1989), 68:541–3.
8. DunlopW, Serial changes in renal haemodynamics during normal human pregnancy. Br J Obstet Gynaecol (1981), 88:1–9.
9. DavisonJM and NobleMC, Serial changes in 24 hour creatinine clearance during normal menstrual cycles and the first trimester of pregnancy. Br J Obstet Gynaecol (1981), 88:10–17.
10. DanielsonLA, SherwoodOD, and ConradKP, Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest (1999), 103:525–33.
11. SmithMC, MurdochAP, DanielsonLA, ConradKP, and DavisonJM, Relaxin has a role in establishing a renal response in pregnancy. Fertil Steril (2006), 86:253–5.
12. LentonEA and WoodwardAJ, The endocrinology of conception cycles and implantation in women. J Reprod Fertil Suppl (1988), 36:1–15.
13. ZakarT and HertelendyF, Progesterone withdrawal: key to parturition. Am J Obstet Gynecol (2007), 196:289–96.
14. Van BurenGA, YangDS, and ClarkKE, Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol (1992), 167:828–33.
15. HagedornKA, CookeCL, FalckJR, MitchellBF, and DavidgeST, Regulation of vascular tone during pregnancy: a novel role for the pregnane X receptor. Hypertension (2007), 49:328–33.
16. CatalanoPM, TyzbirED, WolfeRR, CallesJ, RomanNM, AminiSB, and SimsEA, Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol (1993), 264:E60–7.
17. HomkoCJ, SivanE, ReeceEA, and BodenG, Fuel metabolism during pregnancy. Semin Reprod Endocrinol (1999), 17:119–25.
18. FreinkelN, HerreraE, KnoppRH, and RuderHJ, Metabolic realignments in late pregnancy: a clue to diabetogenesis. Adv Metab Disord (1970), 1(Suppl 1):205+.
19. BarbourLA, McCurdyCE, HernandezTL, KirwanJP, CatalanoPM, and FriedmanJE, Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care (2007), 30(Suppl 2):S112–9.
20. CrossJC and MickelsonL, Nutritional influences on implantation and placental development. Nutr Rev (2006), 64:S12–8; discussion S72–91.
21. OliverMH, JaquieryAL, BloomfieldFH, and HardingJE, The effects of maternal nutrition around the time of conception on the health of the offspring. Soc Reprod Fertil Suppl (2007), 64:397–410.
22. Leunda-CasiA, GenicotG, DonnayI, PampferS, and De HertoghR, Increased cell death in mouse blastocysts exposed to high D-glucose in vitro: implications of an oxidative stress and alterations in glucose metabolism. Diabetologia (2002), 45:571–9.
23. LaneM and GardnerDK, Increase in postimplantation development of cultured mouse embryos by amino acids and induction of fetal retardation and exencephaly by ammonium ions. J Reprod Fertil (1994), 102:305–12.
24. MartinPM and SutherlandAE, Exogenous amino acids regulate trophectoderm differentiation in the mouse blastocyst through an mTOR-dependent pathway. Dev Biol (2001), 240:182–93.
25. KawamuraK, SatoN, FukudaJ, KodamaH, KumagaiJ, TanikawaH, et al., Ghrelin inhibits the development of mouse preimplantation embryos in vitro. Endocrinology (2003), 144:2623–33.
26. BurtonGJ, JauniauxE, and Charnock-JonesDS, Human early placental development: potential roles of the endometrial glands. Placenta (2007), 28(Suppl A):S64–9.
27. RoseboomT, de RooijS, and PainterR, The Dutch famine and its long-term consequences for adult health. Early Hum Dev (2006), 82:485–91.
28. HerreraE, Lopez-SoldadoI, LimonesM, AmusquivarE, and RamosMP, Lipid metabolism during the perinatal phase, and its implications on postnatal development. Int J Vitam Nutr Res (2006), 76:216–24.
29. BailitJL, Hyperemesis gravidarium: epidemiologic findings from a large cohort. Am J Obstet Gynecol (2005), 193:811–14.
30. LumeyLH, SteinAD, and RavelliAC, Timing of prenatal starvation in women and offspring birth weight: an update. Eur J Obstet Gynecol Reprod Biol (1995), 63:197.
31. SymondsME, StephensonT, GardnerDS, and BudgeH, Long-term effects of nutritional programming of the embryo and fetus: mechanisms and critical windows. Reprod Fertil Dev (2007), 19:53–63.
32. MooreVM, DaviesMJ, WillsonKJ, WorsleyA, and RobinsonJS, Dietary composition of pregnant women is related to size of the baby at birth. J Nutr (2004), 134:1820–6.
33. OliverMH, HawkinsP, and HardingJE, Periconceptional undernutrition alters growth trajectory and metabolic and endocrine responses to fasting in late-gestation fetal sheep. Pediatr Res (2005), 57:591–8.
34. OliverMH, HardingJE, BreierBH, and GluckmanPD, Fetal insulin-like growth factor (IGF)-I and IGF-II are regulated differently by glucose or insulin in the sheep fetus. Reprod Fertil Dev (1996), 8:167–72.
35. GallaherBW, BreierBH, HardingJE, and GluckmanPD, Periconceptual undernutrition resets plasma IGFBP levels and alters the response of IGFBP-1, IGFBP-3 and IGF-1 to subsequent maternal undernutrition in fetal sheep. Prog Growth Factor Res (1995), 6:189–95.
36. StockerCJ, ArchJR, and CawthorneMA, Fetal origins of insulin resistance and obesity. Proc Nutr Soc (2005), 64:143–51.
37. ReyE, AttieC, and BoninA, The effects of first-trimester diabetes control on the incidence of macrosomia. Am J Obstet Gynecol (1999), 181:202–6.
38. EricssonA, SaljoK, SjostrandE, JanssonN, PrasadPD, PowellTL, and JanssonT, Brief hyperglycaemia in the early pregnant rat increases fetal weight at term by stimulating placental growth and affecting placental nutrient transport. J Physiol (2007), 581:1323–32.
39. JanssonN, NilsfeltA, GellerstedtM, WennergrenM, Rossander-HulthénL, PowellTL, and JanssonT, Maternal hormones linking maternal body mass index and dietary intake to birth weight. Am J Clin Nutr (2008), 87:1743–9.
40. GluckmanPD, LillycropKA, VickersMH, PleasantsAB, PhillipsES, BeedleAS, et al., Metabolic plasticity during mammalian development is directionally dependent on early nutritional status. Proc Natl Acad Sci U S A (2007), 104:12796–800.
41. DohertyCB, LewisRM, SharkeyA, and BurtonGJ, Placental composition and surface area but not vascularization are altered by maternal protein restriction in the rat. Placenta (2003), 24:34–8.
42. LewisRM, DohertyCB, JamesLA, BurtonGJ, and HalesCN, Effects of maternal iron restriction on placental vascularization in the rat. Placenta (2001), 22:534–9.
43. ReynoldsLP, BorowiczPP, VonnahmeKA, JohnsonML, Grazul-BilskaAA, RedmerDA, and CatonJS, Placental angiogenesis in sheep models of compromised pregnancy. J Physiol (2005), 565:43–58.
44. BarbourLA, ShaoJ, QiaoL, PulawaLK, JensenDR, BartkeA, et al., Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynecol (2002), 186:512–17.
45. HotamisligilGS and SpiegelmanBM, Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes (1994), 43:1271–8.
46. FrostRA and LangCH, Skeletal muscle cytokines: regulation by pathogen-associated molecules and catabolic hormones. Curr Opin Clin Nutr Metab Care (2005), 8:255–63.
47. PeraldiP and SpiegelmanB, TNF-alpha and insulin resistance: summary and future prospects. Mol Cell Biochem (1998), 182:169–75.
48. CatalanoPM, HoeghM, MiniumJ, Huston-PresleyL, BernardS, KalhanS, and Hauguel-De MouzonS, Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia (2006), 49:1677–85.
49. SagawaN, YuraS, ItohH, MiseH, KakuiK, KoritaD, et al., Role of leptin in pregnancy – a review. Placenta (2002), 23(Suppl A):S80–6.
50. IslamiD, BischofP, and ChardonnensD, Possible interactions between leptin, gonadotrophin-releasing hormone (GnRH-I and II) and human chorionic gonadotrophin (hCG). Eur J Obstet Gynecol Reprod Biol (2003), 110:169–75.
51. FantM, MunroH, and MosesAC, An autocrine/paracrine role for insulin-like growth factors in the regulation of human placental growth. J Clin Endocrinol Metab (1986), 63:499–505.
52. HamiltonGS, LysiakJJ, HanVK, and LalaPK, Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res (1998), 244:147–56.
53. OngK, KratzschJ, KiessW, CostelloM, ScottC, and DungerD, Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J Clin Endocrinol Metab 85 (2000):4266–9.
54. LiuYJ, TsushimaT, OnodaN, MineiS, SanakaM, NagashimaT, et al., Expression of messenger RNA of insulin-like growth factors (IGFs) and IGF binding proteins (IGFBP1–6) in placenta of normal and diabetic pregnancy. Endocr J (1996), 43(Suppl):S89–91.
55. Ferguson-SmithAC, CattanachBM, BartonSC, BeecheyCV, and SuraniMA, Embryological and molecular investigations of parental imprinting on mouse chromosome 7. Nature (1991), 351:667–70.
56. HanVK and CarterAM, Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta (2000), 21:289–305.
57. LauMM, StewartCE, LiuZ, BhattH, RotweinP, and StewartCL, Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev (1994), 8:2953–63.
58. DeChiaraTM, EfstratiadisA, and RobertsonEJ, A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature (1990), 345:78–80.
59. ConstanciaM, HembergerM, HughesJ, DeanW, Ferguson-SmithA, FundeleR, et al., Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature (2002), 417:945–8.
60. HardingJE, LiuL, EvansPC, and GluckmanPD, Insulin-like growth factor 1 alters feto-placental protein and carbohydrate metabolism in fetal sheep. Endocrinology (1994), 134:1509–14.
61. IwamotoHS, MurrayMA, and ChernausekSD, Effects of acute hypoxemia on insulin-like growth factors and their binding proteins in fetal sheep. Am J Physiol (1992), 263:E1151–6.
62. FowdenAL, Endocrine regulation of fetal growth. Reprod Fertil Dev (1995), 7:351–63.
63. FowdenAL, LiJ, and ForheadAJ, Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance?Proc Nutr Soc (1998), 57:113–22.
64. FangJ, FureszTC, SmithCH, and FantME, IGF binding protein-1 (IGFBP-1) is preferentially associated with the fetal-facing basal surface of the syncytiotrophoblast in the human placenta. Growth Horm IGF Res (1999), 9:438–44.
65. PardiG and CetinI, Human fetal growth and organ development: 50 years of discoveries. Am J Obstet Gynecol (2006), 194:1088–99.
66. LarqueE, DemmelmairH, BergerB, HasbargenU, and KoletzkoB, In vivo investigation of the placental transfer of (13)C-labeled fatty acids in humans. J Lipid Res (2003), 44:49–55.
67. JanssonT and PowellTL, Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond) (2007), 113:1–13.
68. JonesHN, PowellTL, and JanssonT, Regulation of placental nutrient transport – a review. Placenta (2007), 28:763–74.
69. SibleyCP, TurnerMA, CetinI, AyukP, BoydCA, D'SouzaSW, et al., Placental phenotypes of intrauterine growth. Pediatr Res (2005), 58:827–32.
70. JanssonT and PowellTL, IFPA 2005 Award in Placentology Lecture. Human placental transport in altered fetal growth: does the placenta function as a nutrient sensor? – a review. Placenta (2006), 27(Suppl A):S91–7.
71. JanssonN, PetterssonJ, HaafizA, EricssonA, PalmbergI, TranbergM, et al., Down-regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet. J Physiol (2006), 576:935–46.
72. RoosS, JanssonN, PalmbergI, SaljoK, PowellTL, and JanssonT, Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth. J Physiol (2007), 582:449–59.